SBI CEO Yoshitaka Kitao Says Firm Does not Hold $10B XRP but Owns 9% of Ripple Labs StakeFebruary 16, 2026
Vitalik Buterin Proposes Transaction Simulations to Strengthen Ethereum Wallet SecurityFebruary 23, 2026
Daily Market Update: Bitcoin Drops to $64,300 as Trump’s Tariff Hike Sends Stocks and Crypto LowerFebruary 23, 2026
Dominion Energy (D) Stock: Slips 2.38% Despite Q4 Earnings Beat and Strong 2026 OutlookFebruary 23, 2026
CrowdStrike (CRWD) Stock; Drops Almost 8% After Anthropic’s Claude Shakes Cyber SharesFebruary 23, 2026
Dominion Energy (D) Stock: Slips 2.38% Despite Q4 Earnings Beat and Strong 2026 OutlookFebruary 23, 2026
Finding The Best Crypto to Invest In: Expert Strategies for Identifying Tomorrow’s WinnersFebruary 27, 2025
Best Free Cloud Mining Platforms of 2026: BI DeFi Makes Earning Cryptocurrency Easy for EveryoneFebruary 2, 2026
Cryptorino Review: No KYC Crypto Casino With 100% Bonus & 50 Free Spins, Is it Legit?November 14, 2025
22 Software Expands Blockchain Consulting Services to Help Businesses Navigate Web3 AdoptionDecember 17, 2025
Finding The Best Crypto to Invest In: Expert Strategies for Identifying Tomorrow’s WinnersFebruary 27, 2025
Figure Stock Climbs As Preliminary Q4 Earnings Beat Forecasts And shares Offered Finance February 14, 2026
‘Let’s Go Brandon’ Memecoin Investor Sues Steve Bannon and Trump Advisor Epshteyn Crime February 14, 2026
Grayscale Files S-1 to Convert AAVE Trust Into Spot ETF, Targets NYSE Arca Listing Regulation February 14, 2026
Trump Media (DJT) Stock: Climbs as Truth Social Files for Bitcoin and Ethereum ETFs Stocks February 13, 2026
Enbridge Inc. (ENB) Stock: Record 2025 Earnings, 31st Dividend Hike, $39B Backlog Drive Outlook Stocks February 13, 2026
JPMorgan Highlights Bitcoin Production Cost Drop, Offering Relief to Miners Bitcoin February 13, 2026
Altcoin News February 2026: World Liberty Financial Targets $9.6 Trillion FX Market While Aster Pumps and NEAR Dumps, but DeepSnitch AI Stands a Good Chance at a 300x Rally Tokens February 13, 2026
Intensity Therapeutics (Nasdaq: INTS) Stock: Announces 1-for-25 Reverse Split to Meet Nasdaq Rule Stocks February 13, 2026